Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

HPV-positive head and neck cancer patients fare better than HPV-negative patients

Head and neck cancer patients with HPV-positive tumors tend to survive longer and are more responsive to treatment compared with patients with HPV-negative tumors, according to a study published online February 12 in the Journal of the National Cancer Institute.

13 Feb 2008

Do condoms prevent STD infections other than HIV?

Consistent condom use can reduce the spread of HIV, but are they the answer to rising rates of other sexually transmitted infections?

25 Jan 2008

Cervical cancer rates higher among minority women

The last 50 years have witnessed a dramatic decline in the number of cervical cancer cases, according to the National Cancer Institute.

23 Jan 2008

Previously unknown Merkel cell polyomavirus linked to deadly skin cancer

A new strategy to hunt for human viruses described in this week's issue of the journal Science by the husband-and-wife team who found the cause of Kaposi's sarcoma has revealed a previously unknown virus strongly associated with another rare but deadly skin cancer called Merkel cell carcinoma.

18 Jan 2008

Mouthwash test an easy way to screen for head and neck cancers

Scientists at the Johns Hopkins Kimmel Cancer Center in Baltimore say a simple mouth rinse may provide a new and easy way to screen for head and neck cancers in people who are at high risk for such diseases.

2 Jan 2008

Many cancers caused by infections

Cancer -- popularly understood as a result of mutations or mistakes within the genetic code in cells -- is also caused by infections from viruses, bacteria and parasites.

5 Dec 2007

Latest on research on cancer prevention

Perhaps the best way to fight cancer is to prevent it from developing in the first place.

29 Nov 2007

Alcohol and tobacco use doesn't boost HPV-related cancer risk

Heavy smoking and drinking are known to cause head and neck cancer. Infection with human papillomavirus type 16 (HPV16), a common strain of the sexually-transmitted HPV virus, is another known risk factor for head and neck cancer, which affects about 500,000 people each year worldwide.

27 Nov 2007

New HPV vaccine 'nine-valent' under study

A new vaccine against nine of the most harmful strains of human papillomavirus is under study at the Medical College of Georgia.

19 Nov 2007

Hidden epidemic of sexually transmitted diseases in the U.S.

Health experts in the United States say the country has achieved an all-time record for a sexually transmitted disease.

14 Nov 2007

Review of controversy surrounding the human papillomavirus (HPV) vaccine

In an article appearing in the current issue of Clinical Pharmacology & Therapeutics, experts from the University of Pennsylvania Center for Bioethics and Johns Hopkins Berman Institute of Bioethics review the controversy surrounding the human papillomavirus (HPV) vaccine debate, and its effects on ethical and public health issues.

2 Nov 2007

How one virus mimicks a normal cellular protein to replicate successfully

Both viruses and cancers subvert the growth-control machinery in a cell to serve their own needs.

1 Nov 2007

Significant improvement over current test for human papillomavirus

Iowa State University researchers have developed a technology that detects a single molecule of the virus associated with cervical cancer in women.

31 Oct 2007

Nventa Biopharmaceuticals receives new U.S. patent

Nventa Biopharmaceuticals Corporation has announced that the U.S. Patent and Trademark Office has issued Patent Number 7,262,014 to Nventa covering compositions and methods for inducing or enhancing immune responses to a human papillomavirus (HPV) antigen with or without the use of an adjuvant.

29 Oct 2007

Canadians would welcome HPV vaccine if it were free

Canadians would welcome a vaccine against the human papillomavirus (HPV) if it were introduced at no charge, a Quebec, Canada survey suggests.

24 Oct 2007

HPV test beats Pap in detecting cervical cancer

A new study led by McGill University researchers shows that the human papillomavirus (HPV) screening test is far more accurate than the traditional Pap test in detecting cervical cancer.

18 Oct 2007

HiFi DNA Tech files lawsuit against FDA

A lawsuit was filed Oct. 12 in U.S. District Court against the U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) related to reclassification of HPV DNA tests from class III to class II devices. The inaction by both agencies hinders introduction of new and affordable HPV testing to improve women’s health care.

15 Oct 2007